| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/23/2002 | WO2002039808A1 Method of enhancing virus-resistance in plants and producing virus-immune plants |
| 05/23/2002 | WO2002039807A1 Resistance to gummy stem blight in melon |
| 05/23/2002 | WO2002006324A3 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 05/23/2002 | WO2002006309A3 Novel nucleus export signal peptides (nes), fusion proteins containing the same, and the use thereof |
| 05/23/2002 | WO2002004609A3 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 05/23/2002 | WO2002004595A3 Production of chimeric human papillomavirus |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2002000991A9 Method for improving transfection efficiency |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001095860A3 Probes for chondrogenesis |
| 05/23/2002 | WO2001094545A3 A tumor suppressor pathway in c. elegans |
| 05/23/2002 | WO2001093804A3 Hepatitis c virus conjugates |
| 05/23/2002 | WO2001092313A3 Methods for isolating and using fungal hemolysins |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001090145A3 57805, a human cadherin family member and uses thereof |
| 05/23/2002 | WO2001088117A3 In vitro fucosylation recombinant glycopeptides |
| 05/23/2002 | WO2001085911A3 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |
| 05/23/2002 | WO2001085792A8 Mu-1, member of the cytokine receptor family |
| 05/23/2002 | WO2001085768A3 G-protein coupled receptors and uses therefor |
| 05/23/2002 | WO2001085208A3 Molecular antigen arrays and vaccines |
| 05/23/2002 | WO2001083753A3 Molecules of the nbs/lrr protein family and uses thereof |
| 05/23/2002 | WO2001083730A3 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains |
| 05/23/2002 | WO2001083697A3 System for functional gene discovery in plants |
| 05/23/2002 | WO2001082948A3 Uses of tgap7 for the modulation of leucocyte activation |
| 05/23/2002 | WO2001081577A3 Dna encoding the prost 03 polypeptide |
| 05/23/2002 | WO2001081411A3 Human 7-transmembrane g-protein coupled receptors and polynucleotides encoding the same |
| 05/23/2002 | WO2001081407A3 G protein-coupled receptors |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079277A3 Immunogenic pili presenting foreign peptides, their production and use |
| 05/23/2002 | WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 05/23/2002 | WO2001072837A3 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 05/23/2002 | WO2001072826A3 Oncogenic osteomalacia-related gene 1 |
| 05/23/2002 | WO2001070762A3 Adsorption of polyampholytes to charged surfaces and assays incorporating same |
| 05/23/2002 | WO2001068866A3 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use |
| 05/23/2002 | WO2001064837A8 β NETRIN AND USES THEREOF |
| 05/23/2002 | WO2001063295A3 Dpi-6, a therapeutic biomarker in neurological disorders |
| 05/23/2002 | WO2001049720A3 Chemically modified hiv envelope glycoprotein |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001044269A9 Brain protein markers |
| 05/23/2002 | WO2001040469A3 Tick antigens and compositions and methods comprising them |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001038346A3 Short peptides to target epithelial cells |
| 05/23/2002 | WO2001037872A9 'bonzo' chemokine receptor antibodies and ligands |
| 05/23/2002 | WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 05/23/2002 | WO2001026459A3 Flowering time modification |
| 05/23/2002 | US20020062504 Nuclelotide sequences for use in the generation of plant resistant to viral diseases |
| 05/23/2002 | US20020062500 Hypersensitive response eliciting domains and use thereof |
| 05/23/2002 | US20020062499 Methods for translational repression of gene expression in plants |
| 05/23/2002 | US20020062492 Geneticaly engineered mammals; for use in expressing heterologous proteins |
| 05/23/2002 | US20020062490 Transgenic animal for use in the treatment of blood pressure defects |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062015 Nucleotide sequences coding preferential polypeptides for use in diagnosis and treatment of genetic disorders |
| 05/23/2002 | US20020062014 Expressed sequences of arabidopsis thaliana |
| 05/23/2002 | US20020062013 Novel G protein-coupled receptors |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020062007 Adjusted hemoglobin for use as synthetic blood |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061851 Amino acid sequence of pyroglutamyl-leucinyl-lysinyl-cysteinyl-tyrosinyl-threoninyl-cysteinyl -lysinyl-gluta myl-prolinyl-methioninyl-threoninyl-serinyl-alaninyl-alaninyl-cysteine, in a peptide, is used as antitumor agent |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061847 An isolated polynucleotide encoding the sigma 1 beta receptor, selected from a polynucleotide having prefered nucleotide sequence, or a polynucleotide that hybridize to DNA of above, or polynucletide that differ from DNA of both |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061845 Diagnostic, screening and therapeutic utilization; caspase recruitment domain (CARD) proteins, polypeptides and nucleic acid molecules |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061842 Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses |
| 05/23/2002 | US20020061837 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 05/23/2002 | US20020061836 Modifying drug pharmacokinetics by altering the activity of steroid xenobiotic receptor(SXR) on expression levels of CYP2C8 or MDR1 cytochrome |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061833 Novel molecules of the card-related protein family and uses thereof |
| 05/23/2002 | US20020061590 Nucleotide sequences coding transport protein for use treatment of hematopoietic and immunological defects |
| 05/23/2002 | US20020061578 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering |
| 05/23/2002 | US20020061577 BMP-6 proteins |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061567 Nucleotide sequences coding polypeptide for use in diagnostics, forensics, gene mapping and detection of mutation |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061558 Mouse G protein coupled receptor EDG7 |
| 05/23/2002 | US20020061557 Composition for use in the diagnosis and treatment of fertility defects, mammary gland and prostate cancers, osteoporosis, urogenital disorders and grave's disease |
| 05/23/2002 | US20020061556 Nucleotide sequences coding receptor for use in the diagnosis, treatment, drug screening and monitoring of genetic disorders and physiological defects |
| 05/23/2002 | US20020061555 Generating microorganismal gene expression inhibitors; obtain microorganism, culture, express modulators of gene activity in culture, recover gene expression inhibitors |
| 05/23/2002 | US20020061554 Orphan opioid receptor and recombinant materials for its production |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061552 Nucleotide sequences coding transport protein; for use in the diagnosis, and treatment of cancer |
| 05/23/2002 | US20020061551 Nucleotide sequences coding a regulatory protein for use in the treatment of tumors, arteriosclerosis, autoimmune and diseases, blood disorders, asthma, arthritis and leukemia |
| 05/23/2002 | US20020061546 Assays for protein kinases using fluorescent protein substrates |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061544 Novel polypeptides useful for diagnosis of Aspergillus fumigatus and a process of preparing the same |
| 05/23/2002 | US20020061539 Detecting modulators of binding protein activity; obtain test particle, incubate with binding protein, monitor test particles, determine spacial fit in binding protein, monitor activity of binding protein |
| 05/23/2002 | US20020061525 Sequences of trail variants |
| 05/23/2002 | US20020061524 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 05/23/2002 | US20020061522 1983, 52881, 2398, 45449, 50289, and 52872 novel G protein-coupled receptors and uses therefor |
| 05/23/2002 | US20020061521 Nucleic acids, proteins, and antibodies |
| 05/23/2002 | US20020061520 Polycystic kidney disease PKD2 gene and uses thereof |
| 05/23/2002 | US20020061517 Adenovirus carrying gag gene HIV vaccine |
| 05/23/2002 | US20020061515 Model for neurodegenerative diseases involving amyloid accumulation |
| 05/23/2002 | US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides |
| 05/23/2002 | US20020061512 Zinc finger domains and methods of identifying same |
| 05/23/2002 | US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression |
| 05/23/2002 | US20020061316 Immunotherapeutic stress protein-peptide complexes against cancer |
| 05/23/2002 | US20020061313 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding therefor |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions |